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Purpose: Our previous study indicated that the presence of wheat-specific IgG1 and 
IgG4 antibodies was associated with work-related symptoms in workers exposed to 
wheat flour. We performed this study to investigate the genetic polymorphisms of β2-
adrenergic receptors and wheat-specific antibodies in association with the clinical pa-
rameters of baker’s asthma. Materials and Methods: In total, 379 subjects working 
in a single industrial bakery were enrolled in this study. The skin prick test was per-
formed with common inhalant allergens and wheat flour extract. The presence of se-
rum-specific IgE, IgG1, and IgG4 antibodies to wheat flour were determined by 
ELISA. Whole blood samples were obtained for genotype analysis. Subjects were 
genotyped with regard to five candidate single nucleotide polymorphisms (SNPs) of 
the β2-adrenergic receptor gene (ADRB2; -47 T>C, 46 A>G, 79 C>G, 252 G>A, 
and 523 C>A) using a single-base extension method. Results: No significant associ-
ations were observed between the genotype/allele frequencies of any of the SNPs 
tested and any clinical parameters. The haplotype of ADRB2 (GAA composed of 46 
A>G, 252 G>A, and 523 C>A) was significantly associated with work-related 
symptoms (p<0.05). Moreover, in subjects with the AG or GG genotype at 46 A>G 
and haplotype [GAA] of ADRB2, the prevalence rates of wheat-specific IgG1 anti-
bodies and lower respiratory symptoms increased significantly with exposure inten-
sity (both p<0.05). Conclusion: The findings of the present study suggest that 
ADRB2 genetic polymorphism may contribute to the development of work-related 
symptoms in workers exposed to wheat flour, which can lead to baker’s asthma.
Key Words:    Baker’s asthma, ADRB2 polymorphism, haplotype, specific IgG an-
tibody
INTRODUCTION
Baker’s asthma and rhinitis are among the most common occupational respiratory 
disorders in Western countries.1-4 In the pathophysiology of occupational asthma, 
exposure intensity to occupational allergens is a widely known risk factor for work-ADRB2 Polymorphism in Workers Exposed to Wheat Flour
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The methacholine challenge test was performed in 16 
subjects with suspected airway hyperresponsiveness, and 
the concentration of inhaled methacholine that causes a 
20% fall in FEV1 (PC20) was measured. A bronchoprovoca-
tion test with wheat flour was performed in subjects with 
positive results in the methacholine challenge test as de-
scribed previously.14 Briefly, normal saline was adminis-
tered from a nebulizer connected to a dosimeter (646; Dev-
ilbiss Co, Somerset, PA, USA). The subject was asked to 
breathe each graded dosing of wheat extracts 5 times using 
dosimeter. The concentrations of inhaled wheat extract 
ranged from 1 mg/mL to 1 mg/mL, which were decided as 
the previous results of intradermal tests with wheat extracts. 
Lung function was measured with a spirometer (Jaeger) be-
fore and 10 minutes after each dosing of inhalation. Then, 
lung functions were measured every 10 minutes during the 
first hour, and every hour for 7 hours after the challenge. 
When the FEV1 level decreased more than 20% from the 
baseline value, it was regarded as a positive response. 
All subjects were classified according to their dust expo-
sure density as described previously.14 Subjects were briefly 
classified by their current task. The minimal exposure group 
included packaging, supplies, development, shipping, ac-
count, distribution, and other office jobs. The intermediate 
group included foaming, baking (oven), decoration and 
production manager. The high exposure group included 
mixing, weighing, and dividing tasks. 
Genotyping
Genomic DNA was prepared from whole blood samples 
using a Puregene DNA purification kit (Gentra Systems, 
Minneapolis, MN, USA) according to the manufacturer’s 
protocol. Genotyping of each polymorphism was per-
formed using a single-base extension method. Five ADRB2 
polymorphisms (-47, 46, 79, 252, and 523; numbers are rel-
ative to the first nucleotide of the start codon as +1) were 
screened using a single-base extension method. The used 
primer sequences are listed below: forward 5’-TGAATGAG 
GCTTCCAGGC-3’, reverse 5’-GTRAGCGCACTGGCT 
GGG-3’, and extension 5’-CXCGCAGAGCXCCGCCGT 
GGGTCCGCC-3’ for -47 T>C; forward 5’-CAGGAAACA 
GCTATGACCGCACATAACGGGCAGAAC-3’, reverse 
5’- CCAGTGAAGTGATGAAGTAGTTG-3’, and extension 
5’-ACGTCRTGGTCCGGCGCATGGCTTC-3’ for 46 A>G; 
forward 5’-TTCTTGCTGGCACCCAAT-3’, reverse 5’-GA 
CATGACGATGCCCATG-3’, and extension 5’- TGCGCC 
GGACCACGXCGXCACGCAG-3’ for 79C>G; forward 
related symptoms, and many studies have suggested close 
correlations between wheat flour allergen exposure and 
wheat flour sensitization.5-7 IgE-mediated response is a ma-
jor pathogenic mechanism in the development of baker’s 
asthma.8-10 In addition, wheat-specific IgG and IgG subclass-
es have also been suggested to be involved in the pathogen-
esis of baker’s asthma.11-13 In our previous study, we demon-
strated that the prevalence rates of serum wheat-specific 
IgG1 and IgG4 antibodies increased with exposure intensity 
and that they were also significantly associated with the 
presence of work-related symptoms.14 
Although human leukocyte antigen (HLA) haplotypes 
and genetic polymorphisms are associated with some occu-
pational asthma,15 no previous studies have reported any as-
sociation between genetic polymorphisms and baker’s asth-
ma. However, several genetic studies have demonstrated 
that the β2-adrenergic receptor (ADRB2) polymorphism 
was associated with asthma phenotype16 and pharmacoge-
netic aspects.17,18 Based on our previous epidemiological 
and immunological data, we investigated ADRB2 genetic 
polymorphisms associated with the clinical findings of work-
ers exposed to wheat flour in a single factory bakery. 
MATERIALS AND METHODS
Study population
The protocols of this study were reviewed and approved by 
the Ajou University Institute Review Board. Informed con-
sent was obtained from each participant. 
In total, 379 subjects from our previous study who 
agreed to provide whole blood samples for genetic analysis 
were enrolled in the present study.14 All subjects completed 
a respiratory questionnaire regarding whether they had had 
work-related and/or lower-respiratory symptoms. Skin 
prick tests (SPT) were performed and included common in-
halant allergens and wheat flour extract. Atopy was defined 
for subjects with more than one positive response to com-
mon inhalant allergens on the skin prick test. Serum total 
IgE levels were measured by the immunoCAP system 
(Phadia AB, Uppsala, Sweden). The presence of specific 
IgE, IgG1, and IgG4 antibodies to wheat extracts was de-
termined by an enzyme-linked immunosorbent assay (ELI-
SA), as described previously.19 Lung functions, including 
forced expiratory volume in 1 s (FEV1) were measured 
with a spirometer (Jaeger; MasterScope PC, Hoechberg, 
Germany). Gyu-Young Hur, et al.
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ings, including age, gender, working duration, prevalence 
rates of symptoms, results of skin prick tests, and presence 
of wheat-specific IgE antibody. The mean age of the sub-
jects was 34.92±7.72 years, and 56.7% were male. The 
mean working duration in the baking industry was 
3.96±3.48 years, and the prevalence rate of atopy was 
34.6%. Sixty-five subjects (17.1%) had work-related symp-
toms and 52 (13.7%) exhibited lower-respiratory symptoms. 
The prevalence rates of wheat-specific IgE antibody and 
positive skin prick test results to wheat flour were 6.6% and 
6.1%, respectively. The mean PC20 value was 17.82±10.94 
mg/mL, and six subjects showed a positive response to the 
bronchoprovocation test with wheat flour. 
The associations of the clinical parameters according to 
each ADRB2 genotype are presented in Table 2. There were 
no significant associations between clinical parameters and 
genotypes. 
Associations between SNPs and the haplotype of 
ADRB2
Table 3 summarizes the associations of five SNPs of ADRB2 
with work-related symptoms. The prevalence of work-relat-
ed symptoms was higher in subjects with GA or AA geno-
types of 252 G>A, or the CA or AA genotypes of 523 C>A 
(p<0.05, respectively). However, the statistical significance 
disappeared after performing Bonferroni’s multiple compar-
isons. The results of power analysis were 0.56 for 252 G>A 
(effect size 0.11), and 0.61 for 523 C>A (effect size 0.15). 
Table 4 shows the associations of these haplotypes with 
5’-CAACTACTTCATCACTTCACTGR-3’, reverse 
5’-ACATTTTCATAAGAATATGGGCG-3’, and extension 
5’-CCTGTGCTGATCTGGTCATGGGCCT-3’ for 252 
G>A; and forward 5’-ATTGTGTCAGGCCTTACCTCR-3’, 
reverse 5’-GTCTCATTGGCATAGCAGTTG-3’, and ex-
tension 5’-CTTGCCCATTCAGATGCACTGGTAC-3’ for 
523 C>A. 
Primer extension reactions were performed with a SNaP-
shot ddNTP primer extension kit (Applied Biosystems, 
Foster City, CA, USA). PCR reactions were carried out as 
follows: denaturations were done as 1 cycle at 95°C for 10 
minutes, and 35 cycles at 95°C for 30 seconds. Melting pro-
cesses were done at 55°C for -47T>C, 46A>G, 79C>G, and 
523C>A SNPs, at 50°C for 252G>A SNP for 1 minute. Ex-
tensions were done at 72°C for 1 minute. The results were 
analyzed after completion of the study using the ABI Prism 
GeneScan and Genotyper software (Applied Biosystems).
Statistical analyses
All data are expressed as means±standard deviation. SPSS 
software (version 11.05; SPSS Inc., Chicago, IL, USA) was 
used for statistical analyses. 
Estimation of haplotypes was performed using Haplo-
view (version 3.32; Broad Institute, Cambridge, MA, 
USA), and three haplotype sets were derived from 46 A>G, 
252 G>A, and 523 C>A of ADRB2 SNPs. Significant de-
partures of the genotype frequency from Hardy-Weinberg 
equilibrium at the polymorphic site were tested by χ2 analy-
sis. The clinical parameters of the subjects were compared 
with each genotype using ANOVA and χ2 analysis. The as-
sociations of each polymorphic genotype/haplotype in the 
study subjects with work-related symptoms were analyzed 
using Fisher’s exact test. Power analysis was performed us-
ing PASS (version 2005; NCSS, Kaysville, UT, USA). All 
values were adjusted using Bonferroni’s multiple compari-
son tests to correct for incidental significance.
Predictive probability was calculated for the presence of 
serum-specific IgG subclasses to wheat flour in subjects 
with ADRB2 genetic polymorphism or haplotype using lo-
gistic regression.20 All data was adjusted for age, sex, atopy 
status, and exposure density using logistic regression. 
RESULTS
           
Subject characteristics and clinical findings
Table 1 shows the subject characteristics and clinical find-
Table 1. Clinical Characteristics of the Subjects 
Mean±SD, n
Age (yrs) 34.92±7.72
Male 215/379 
Working period (yrs) 3.96±3.48
Atopy 131/374 
Smoking 147/350 
Work-related symptoms   65/379 
Lower respiratory symptoms   52/379 
FEV1 (L) 3.18±0.74
Log total IgE (kU/L) 4.40±1.47
Presence of specific IgE to wheat flour   25/378 
Positive SPT response to wheat flour   23/374 
PC20 to methacholine (mg/mL)* 17.82±10.94
Positive response of BPT with wheat flour     6/379 
*The methacholine challenge test was performed in only 16 subjects with 
suspected airway hyperresponsiveness. 
PC20, the concentration of inhaled methacholine that causes a 20% fall in 
FEV1; BPT, bronchoprovocation test.ADRB2 Polymorphism in Workers Exposed to Wheat Flour
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intermediate to high) by a logistic regression model as 
shown in Figs. 1 and 2. In subjects with AG or GG geno-
type of ADRB2 46 A>G, prevalence rates of serum-specific 
IgG1 and IgG4 antibodies to wheat flour increased signifi-
cantly with higher exposure intensity [odds ratio (OR) 
2.524, p<0.001, Fig. 1A; OR 5.097, p=0.002, Fig. 1B]. No 
significant changes were found in those with the AA geno-
type, which was replicated in the results of the haplotype 
analysis, as the subjects with HT2 [GAA] had a significant-
ly higher prevalence rate of serum-specific IgG1 antibody 
to wheat flour in relation to exposure intensity (OR 2.652, 
p=0.002) (Fig. 2A). The subjects with this HT2 haplotype 
also showed a higher risk of having LRS in relation to ex-
posure intensity (OR 2.019, p=0.014) (Fig. 2B). 
WRS. When the haplotype of ADRB2 was composed of 46 
A>G, 252 G>A, and 523 C>A, the prevalence rate of work-
related symptoms was significantly higher in subjects with 
than in those without HT2 [GAA] (p<0.05). The power anal-
ysis result was 0.56 for HT2 [GAA] (effect size 0.11). 
Predictive probabilities for serum-specific IgG 
subclasses to wheat flour
No significant associations were observed between the gen-
otypes of five SNPs and prevalence rates of serum-specific 
IgE, IgG1, and IgG4 antibodies (all p>0.05, data not shown). 
However, the predicted probabilities for the presence of se-
rum-specific IgG1 and IgG4 antibodies to wheat flour were 
calculated according to the exposure intensity (minimal and 
Table 2. Clinical Parameters According to Each ADRB2 Genotype  
ADRB2  - 47 T>C  46 A>G 79 C>G 252 G>A 523 C>A
Age (yrs) 0.818  0.385 0.901 0.503 0.618
Male 0.120 0.688 0.117 0.525 0.352
Working period (yrs) 0.088  0.768  0.088  0.353  0.444 
Atopy 0.806 0.909 0.822 0.762 0.644
Smoking 0.544 0.101 0.523 0.080 0.119
Work-related symptoms 0.652 0.257 0.656 0.097 0.079
Lower respiratory symptoms 0.688 0.891 0.656 0.108 0.316
FEV1 (L) 0.548 0.598 0.514 0.546 0.393
Log total IgE (kU/L) 0.629 0.223 0.629 0.206 0.308
Presence of specific IgE to wheat flour 0.744 0.751 0.744 0.821 0.958
Positive SPT response to wheat flour 0.650 0.732 0.660 0.913 0.807
*Associations were presented as p value compared to each genotype using ANOVA and χ2-test. 
Table 3. Associations of ADRB2 SNPs with Work-Related Symptoms 
Work-related symptoms
p value
Present (%) Absence (%)
- 47 T>C
    TT  53/65 (81.5) 248/310 (80) NS
    TC or CC  12/65 (18.5) 62/310 (20)
46 A>G
    AA  13/65 (20)   92/306 (30.1) NS
    AG or GG  52/65 (80) 214/306 (69.9)
79 C>G
    CC  53/65 (81.5) 251/313 (80.2) NS
    CG or GG  12/65 (18.5)   62/313 (19.8)
252 G>A
    GG  19/64 (29.7) 138/314 (43.9) 0.037
    GA or AA 45/64 (70.3) 176/314 (56.0)
523 C>A
    CC  19/65 (29.2) 139/314 (44.3) 0.027
    CA or AA 46/65 (70.8) 175/314 (55.7)
SNP, single nucleotide polymorphism; WRS, work-related symptoms; NS, not significant; ADRB2, β2-adrenergic receptor 2; IL-13, inter-
leukin-13; IFNGR2, interferon-γ receptor 2. Gyu-Young Hur, et al.
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Table 4. Associations between β2-Adrenergic Receptor Gene Haplotypes and Work-Related Symptoms 
　  Work-related symptoms
p value
　  Presence (%) Absence (%)
HT1[AGC]*
    +/+  13/64 (20.3)   90/297 (30.3) NS
    +/-  34/64 (53.1) 144/297 (48.5) NS
    -/-  17/64 (26.6)   63/297 (21.2) NS
HT2[GAA]*
    +/+  10/64 (15.6)   33/297 (11.1) 0.098
    +/-  35/64 (54.7) 133/297 (44.8) 0.036
    -/-  19/64 (29.7) 131/297 (44.1) 0.295
HT3[GGC]*
    +/+  1/64 (1.6)   1/297 (0.3) NS
    +/-  11/64 (17.2)   63/297 (21.2) NS
    -/-  52/64 (81.3) 233/297 (78.5) NS
HT4[Others]*
    +/+  NA NA NS
    +/-  0/64 (0.0)   6/297 (2.0) NS
    -/-    64/64 (100.0) 291/297 (98.0) NA
*The haplotype was composed of 46A>G, ADRB2 252G>A, and 523C>A β2-adrenergic receptor polymorphisms. 
WRS, work-related symptoms; NS, not significant; HT, haplotype; NA, not available. 
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Fig. 1. Predictive probabilities for the presence of serum-specific IgG antibodies to wheat flour in relation to exposure, according to the 
ADRB2 46A>G polymorphism. 
Fig. 2. Predictive probabilities for the presence of serum-specific IgG antibodies to wheat flour in relation to exposure density, according to the 
genotype of ADRB2. *The haplotype was composed of 46A>G, 252G>A, and 523C>A of the β2-adrenergic receptor genetic polymorphism. 
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ence, since the ADRB2 gene is located at 5q31-q32, not on 
the X chromosome. In this study, we could not find any sig-
nificant gender differences in allele frequency (data not 
shown). 
In the present study, HT2 [GAA], including the ADRB2 
46 G allele, was significantly associated with the presence of 
work-related symptoms. Considering the importance of ge-
netic susceptibility and environmental exposure to the devel-
opment of baker’s asthma, the subjects in this study were 
classified into two groups according to the intensity of expo-
sure. The results indicated that subjects with HT2 [GAA] 
showed significantly greater lower-respiratory symptoms 
with increasing intensity of exposure to wheat flour. More-
over, the subjects with the G allele at ADRB2 46 A>G had 
significantly higher prevalence rates of serum-specific IgG1 
and IgG4 to wheat flour with increasing exposure intensity. 
In our previous study, the presence of serum wheat-specific 
IgG4 antibodies was associated with the presence of work-
related symptoms and work-related lower-respiratory symp-
toms.14 The presence of serum-specific IgG1 to wheat may 
represent exposure to wheat flour in exposed workers. 
These findings suggest that workers with the AG/GG geno-
type of ADRB2 46 A>G are at a higher risk of generating 
wheat-specific IgG1 and IgG4 antibodies with increasing 
exposure intensity. Subjects with this haplotype of ADRB2 
HT2 [GAA] may have greater genetic susceptibility to de-
veloping work-related lower-respiratory symptoms with in-
creasing exposure intensity.
However, there are some limitations to this study. Ethnic 
differences should be considered. Since this study is limited 
to a Korean population, the results may not be applicable to 
other populations because genotypic distribution appears to 
differ among races. The prevalence of baker’s asthma and 
the number of study subjects were also relatively low in 
this study population. 
In conclusion, we speculate that ADRB2 polymorphism 
may be associated with the presence of specific IgG and 
work-related symptoms in workers who have high expo-
sure to wheat flour, which can lead to the development of 
baker’s asthma.
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DISCUSSION
Environmental and genetic backgrounds play important 
roles in the development of bronchial asthma. Occupational 
asthma is defined as a disease characterized by variable air-
flow limitation with airway hyperresponsiveness that is at-
tributable to a particular occupational environment.21 Bak-
er’s asthma is a common occupational disease, with wheat 
flour being one of the common causative agents of occupa-
tional asthma.22,23 The working environment is known to be 
the most important factor associated with baker’s asthma, 
but no previous studies have examined genetic polymor-
phisms in subjects with this condition. This is the first study 
to investigate genetic susceptibility in association with im-
mune responses to wheat flour and work-related symptoms.
Several genetic studies have investigated ADRB2 with 
regard to phenotype and the pharmacogenetic aspects of 
asthma, particularly in association with the bronchodilating 
effect of β-agonist use,17 and reports have described the 
presence of common functional polymorphic variants of 
the ADRB2 gene.18 Thirteen polymorphisms in this gene 
and its transcriptional regulator β upstream peptide have 
been identified to date.24 Among these, many have reported 
on the associations of 46 A>G polymorphisms and indicat-
ed that the Gly mutation at this position increases the risk of 
severe asthma16 and airway hyperresponsiveness.25 In addi-
tion, pharmacogenetic studies have shown that ADRB2 
polymorphism can modify the bronchodilator response to 
β-agonists.17,26 
Caucasian individuals with the Gly/Gly genotype of 
ADRB2 46 A>G have a greater bronchodilator response to 
the use of β-agonists. However, different findings have 
been reported in Korean populations, in that patients with 
asthma who had the homozygous Arg/Arg genotype showed 
a significantly greater response to short-acting β2-agonist.27 
Such differing results were reported in other ethnic groups.28 
Therefore, ethnic differences play a major role in determin-
ing the bronchodilator responses to β-agonist. 
With regard to other ADRB2 SNPs, polymorphisms at 
ADRB2 -47 T>C located in the β upstream peptide were 
reported to be associated with the bronchodilator response 
in African-American patients with asthma.29 Polymorphism 
at ADRB2 523 C>A was also shown to be associated with 
the bronchodilator response in an American population.30 In 
addition, there have been no data collected regarding the 
associations between allele frequency and gender differ-Gyu-Young Hur, et al.
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asthmatic subjects. Am J Respir Cell Mol Biol 1993;8:334-9.
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asthma: genotype-stratified, randomised, placebo-controlled cross-
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Association between bronchodilating response to short-acting be-
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Beta 2-adrenergic receptor polymorphisms: pharmacogenetic re-
sponse to bronchodilator among African American asthmatics. 
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